Streetbeat News

Analyst Ratings

VLO

B of A Securities analyst Doug Leggate maintains a Neutral rating on Valero Energy (NYSE:VLO) and raises the price target from $152 to $161.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:40 pm

MPC

B of A Securities analyst Doug Leggate maintains a Neutral rating on Marathon Petroleum (NYSE:MPC) and raises the price target from $162 to $173.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:39 pm

PSX

B of A Securities analyst Doug Leggate maintains a Neutral rating on Phillips 66 (NYSE:PSX) and raises the price target from $141 to $143.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:38 pm

PBF

B of A Securities analyst Doug Leggate maintains a Neutral rating on PBF Energy and raises the price target from $56 to $65.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:37 pm

DINO

B of A Securities analyst Doug Leggate maintains a Neutral rating on HF Sinclair (NYSE:DINO) and raises the price target from $65 to $70.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:36 pm

HURN

Truist Securities analyst Tobey Sommer has maintained a 'Buy' rating on Huron Consulting Gr (NASDAQ:HURN) and raised the price target from $100 to $130.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:35 pm

PTCT

Truist Securities analyst Barry Jonas has maintained a 'Buy' rating on PTC Therapeutics (NASDAQ:PTCT), but lowered the price target from $60 to $45.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:34 pm

RMD

B of A Securities analyst Lyanne Harrison maintains a Buy rating on ResMed (NYSE:RMD) but lowers the price target from $250 to $230.

Portfolio Pulse from Benzinga Newsdesk

September 18, 2023 | 5:33 pm

ABBV

A significant bearish stance has been taken on AbbVie (NYSE:ABBV) by a large investor or institution, as indicated by unusual options activity. The overall sentiment of these big-money traders is 18% bullish and 81% bearish. The whales have been targeting a price range from $125.0 to $160.0 for AbbVie over the last 3 months. The price of ABBV is currently up 1.06% at $153.73, and the next earnings are expected to be released in 39 days.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:31 pm

SHOP

A whale investor has taken a bullish stance on Shopify (NYSE:SHOP), with 66% of investors opening trades with bullish expectations and 33% with bearish. The whale has been targeting a price range from $40.0 to $105.0 for Shopify over the last 3 months. The price of SHOP is currently down -3.43% at $60.24. Wedbush, Canaccord Genuity, and Roth MKM have given price targets of $62, $70, and $76 respectively.

Portfolio Pulse from Benzinga Insights

September 18, 2023 | 5:31 pm